INR 12.41
(-7.87%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 371.16 Million INR | -3.28% |
2022 | 383.76 Million INR | -30.57% |
2021 | 552.69 Million INR | -13.24% |
2020 | 637.04 Million INR | 42.13% |
2019 | 448.22 Million INR | -5.34% |
2018 | 473.52 Million INR | 8.3% |
2017 | 437.21 Million INR | 7.21% |
2016 | 407.8 Million INR | -12.34% |
2015 | 465.18 Million INR | 9.3% |
2014 | 425.6 Million INR | -15.48% |
2013 | 503.56 Million INR | 9.93% |
2012 | 458.08 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q2 | 358.91 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 371.16 Million INR | -3.28% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 371.16 Million INR | 0.0% |
2022 FY | 383.76 Million INR | -30.57% |
2022 Q4 | 383.76 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 450.12 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 FY | 552.69 Million INR | -13.24% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 552.69 Million INR | 0.0% |
2021 Q2 | 499.09 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q1 | 441.06 Million INR | -1.6% |
2020 Q4 | 637.04 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 637.04 Million INR | 42.13% |
2020 Q2 | 417.3 Million INR | -5.39% |
2019 Q2 | 474.24 Million INR | 0.0% |
2019 FY | 448.22 Million INR | -5.34% |
2019 Q4 | 448.22 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q1 | 399.1 Million INR | -8.72% |
2018 FY | 473.52 Million INR | 8.3% |
2018 Q4 | 473.52 Million INR | 0.0% |
2018 Q3 | 473.52 Million INR | 18.64% |
2018 Q2 | 399.1 Million INR | 0.0% |
2017 FY | 437.21 Million INR | 7.21% |
2017 Q1 | - INR | 0.0% |
2017 Q2 | 377.05 Million INR | 0.0% |
2017 Q4 | 437.21 Million INR | 0.23% |
2017 Q3 | 436.2 Million INR | 15.69% |
2016 FY | 407.8 Million INR | -12.34% |
2015 FY | 465.18 Million INR | 9.3% |
2014 FY | 425.6 Million INR | -15.48% |
2013 FY | 503.56 Million INR | 9.93% |
2012 FY | 458.08 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Amrutanjan Health Care Limited | 783.82 Million INR | 52.647% |
Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -28.519% |
Caplin Point Laboratories Limited | 3.5 Billion INR | 89.412% |
FDC Limited | 3.7 Billion INR | 89.993% |
Gufic Biosciences Limited | 5.59 Billion INR | 93.372% |
Hikal Limited | 12.99 Billion INR | 97.144% |
Ind-Swift Laboratories Limited | 2.28 Billion INR | 83.788% |
IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 94.135% |
Kilitch Drugs (India) Limited | 643.88 Million INR | 42.356% |
Medico Remedies Limited | 438.24 Million INR | 15.307% |
Nectar Lifesciences Limited | 11.21 Billion INR | 96.691% |
Par Drugs and Chemicals Limited | 159.79 Million INR | -132.28% |
RPG Life Sciences Limited | 1.38 Billion INR | 73.108% |
Sequent Scientific Limited | 8.27 Billion INR | 95.514% |
Shilpa Medicare Limited | 12.93 Billion INR | 97.13% |
Sigachi Industries Limited | 2.53 Billion INR | 85.337% |
Themis Medicare Limited | 1.88 Billion INR | 80.336% |
Unichem Laboratories Limited | 8.06 Billion INR | 95.4% |
Venus Remedies Limited | 1.39 Billion INR | 73.351% |
Wanbury Limited | 3.15 Billion INR | 88.238% |
ZIM Laboratories Limited | 2.08 Billion INR | 82.162% |
Lupin Limited | 96.23 Billion INR | 99.614% |
Innova Captab Limited | 4.89 Billion INR | 92.425% |
Ind-Swift Limited | 13.45 Billion INR | 97.241% |
Bajaj HealthCare Limited | 4.86 Billion INR | 92.375% |
Aurobindo Pharma Limited | 152.2 Billion INR | 99.756% |
Solara Active Pharma Sciences Limited | 14.09 Billion INR | 97.366% |
AstraZeneca Pharma India Limited | 3.66 Billion INR | 89.862% |
Mangalam Drugs & Organics Limited | 1.97 Billion INR | 81.219% |
Morepen Laboratories Limited | 4.45 Billion INR | 91.678% |
Laurus Labs Limited | 42.71 Billion INR | 99.131% |
Aarti Drugs Limited | 11.5 Billion INR | 96.774% |
Glenmark Life Sciences Limited | 5.18 Billion INR | 92.836% |
Alembic Limited | 1.43 Billion INR | 74.083% |
Alembic Pharmaceuticals Limited | 16.27 Billion INR | 97.719% |
Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 99.43% |
Aarti Pharmalabs Limited | 8.25 Billion INR | 95.501% |
Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -25.072% |
Jubilant Pharmova Limited | 61.27 Billion INR | 99.394% |
Eris Lifesciences Limited | 38.26 Billion INR | 99.03% |
Windlas Biotech Limited | 1.76 Billion INR | 78.943% |
Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 99.798% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 65.459% |
Orchid Pharma Limited | 3.84 Billion INR | 90.345% |
Albert David Limited | 1.15 Billion INR | 67.728% |
Hester Biosciences Limited | 3.59 Billion INR | 89.675% |
Sakar Healthcare Limited | 1.26 Billion INR | 70.619% |
Suven Pharmaceuticals Limited | 2.03 Billion INR | 81.754% |
Procter & Gamble Health Limited | 2.56 Billion INR | 85.508% |
Divi's Laboratories Limited | 18.99 Billion INR | 98.045% |
Mankind Pharma Limited | 23.87 Billion INR | 98.445% |
Neuland Laboratories Limited | 5.49 Billion INR | 93.25% |
J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 96.534% |
Zydus Lifesciences Limited | 71.79 Billion INR | 99.483% |
Wockhardt Limited | 39.87 Billion INR | 99.069% |
Bal Pharma Limited | 2.51 Billion INR | 85.22% |
Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 99.653% |
Bliss GVS Pharma Limited | 2.1 Billion INR | 82.4% |
Alkem Laboratories Limited | 48.6 Billion INR | 99.236% |
Valiant Laboratories Limited | 1.05 Billion INR | 64.927% |
Ajanta Pharma Limited | 10.71 Billion INR | 96.535% |
Bafna Pharmaceuticals Limited | 652.27 Million INR | 43.098% |
Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | 78.448% |
Granules India Limited | 22.95 Billion INR | 98.383% |
Medicamen Biotech Limited | 940.36 Million INR | 60.53% |
Ipca Laboratories Limited | 33.74 Billion INR | 98.9% |
Brooks Laboratories Limited | 248.6 Million INR | -49.301% |
Syncom Formulations (India) Limited | 1.16 Billion INR | 68.146% |
Piramal Enterprises Limited | 560.47 Billion INR | 99.934% |
Torrent Pharmaceuticals Limited | 82.05 Billion INR | 99.548% |
NATCO Pharma Limited | 10.53 Billion INR | 96.476% |
Suven Life Sciences Limited | 148.62 Million INR | -149.738% |
Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 87.519% |
Strides Pharma Science Limited | 37.68 Billion INR | 99.015% |
Indoco Remedies Limited | 10.34 Billion INR | 96.411% |
Alpa Laboratories Limited | 307.12 Million INR | -20.852% |
Lasa Supergenerics Limited | 541.92 Million INR | 31.51% |
Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 90.466% |